Ana Blanco

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

Belén Atienza‐Mateo, J. L. Martín-Varillas, V. Calvo-Río et al. · Arthritis & Rheumatology · 2019 · 110 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +9

High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results

Pedro J. Prada, Juan Cardenal, Ana Blanco et al. · Radiotherapy and Oncology · 2016 · 108 citations

Medicine, Oncology, Urology +11

Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

Leyre Riancho‐Zarrabeitia, V. Calvo-Río, Ricardo Blanco et al. · Seminars in Arthritis and Rheumatism · 2015 · 89 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients

L. Sánchez-Bilbao, D. Martínez-López, Marcelino Revenga et al. · Journal of Clinical Medicine · 2020 · 88 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

J. L. Martín-Varillas, V. Calvo-Río, E. Beltrán et al. · Ophthalmology · 2018 · 70 citations · Full text

Medicine, Immunology, Ophthalmology +13